Both in Pharmaceuticals
USANA Health Sciences vs Immuneering
Over the past year USNA returned −30.0% and IMRX returned −43.9%; their daily moves had a correlation of -0.05.
USNA −30.0% IMRX −43.9%Growth of $1, one year, split-adjusted
| Metric | USNA | IMRX |
|---|---|---|
| Price | $14.87 | $3.68 |
| Market cap | $274.7M | $238.3M |
| Today | +1.02% | +5.44% |
| 1 month | +0.1% | −8.9% |
| 6 months | −22.8% | −31.1% |
| Year to date | −24.2% | −44.1% |
| 1 year | −29.7% | −46.4% |
| Revenue growth (YoY) | −5.3% | — |
| Gross margin | 78.3% | — |
| Net margin | −9.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | — |
| Net cash | $168.6M | $145.4M |
| Dividend yield | — | — |
| Volatility (60d) | 34.9% | 53.8% |
| Short % of float | 7.2% | 29.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).